Articles related to BREAST CANCER

Discover how sacituzumab govitecan is setting a new standard in the treatment of HR+, HER2- metastatic breast cancer, offering improved survival rates and lower risks of progression.

This case of Mondor disease highlights the importance of accurate diagnosis and patient education. Learn how to differentiate this benign condition from more serious underlying issues.

New research questions the life-extending efficacy of most common cancer screenings, emphasizing the need for transparent physician-patient discussions to weigh the risks and benefits. Learn more about this crucial topic that might change your approach to recommending screenings.

This meta-analysis points to ovarian suppression as a potent strategy for enhancing survival rates and reducing recurrence in pre-menopausal women with early-stage breast cancer.

This prospective cohort study presents compelling evidence that omitting radiotherapy in women over 55 with specific luminal A breast cancer characteristics may lead to a low incidence of local recurrence at 5 years.

This retrospective cohort study provides a detailed analysis of overdiagnosis in breast cancer screening among women aged 70 and above. Physicians are encouraged to explore the findings to better understand the implications of screening practices for older women.